featured
Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
N. Engl. J. Med 2017 Nov 04;[EPub Ahead of Print], VE Torres, AB Chapman, O Devuyst, RT Gansevoort, RD Perrone, G Koch, J Ouyang, RD McQuade, JD Blais, FS Czerwiec, O SergeyevaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.